Factors of the epidemiological triad that influence the persistence of human papilloma virus infection in women with systemic lupus erythematosus

Lupus

Volumn 27, Issue 9, 2018, Pages 1542-1546

  Mendez Martinez S ^a,b   Garcia Carrasco M ^a,b   Jimenez Herrera E A ^b   Mendoza Pinto, C ^a,b   Etchegaray Morales, I ^b   Barahona Rubio, P W ^c   Galvez Romero J L ^b,d   Munguia Realpozo P ^b   Munoz Guarneros C O ^a   Cedillo Ramirez M L ^a   Silva Gomez S E ^a   Linares Fleites, G ^a   Rojas Vallaraga, A ^e  

^a BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c UNIVERSIDAD AUTÓNOMA DE GUADALAJARA   (Mexico)

^d Hospital Regional de Puebla   (Mexico)

^e UNIVERSIDAD DEL ROSARIO   (Colombia)

Author keywords

Epidemiologic triad; epidemiology; HPV; systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CHLOROQUINE; CONTRACEPTIVE AGENT; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MYCOPHENOLATE MOFETIL; ORAL CONTRACEPTIVE AGENT; PREDNISONE; VITAMIN D;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; EDUCATIONAL STATUS; ENVIRONMENTAL FACTOR; FEMALE; GENOTYPE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; MEXICAN; MIXED INFECTION; MYCOPLASMA; PAPILLOMAVIRUS INFECTION; POVERTY; PREVALENCE; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SEXUALITY; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRAL CLEARANCE; VITAMIN D DEFICIENCY; COHORT ANALYSIS; COMPLICATION; ENVIRONMENT; MEXICO; MIDDLE AGED; VIROLOGY; YOUNG ADULT;

ADULT; AGED; COHORT STUDIES; ENVIRONMENT; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MEXICO; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; YOUNG ADULT;

EID: 85050409709     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203318773176     Document Type: Article

References (15)

1. Smith JS, Melendy A, Rana RK, Pimenta JM. Age-specific prevalence of infection with human papillomavirus in females: A global review. J Adolesc Health 2008; 43 4 Suppl: S5-25, S25.e1–e41
2. Saslow D, Solomon D, Lawson HW, American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. J Low Genit Tract Dis 2012; 16: 175–204
3. Aguilar-Lemarroy A, Vallejo-Ruiz V, Cortés-Gutiérrez EI, Human papillomavirus infections in Mexican women with normal cytology, precancerous lesions, and cervical cancer: Type-specific prevalence and HPV coinfections. J Med Virol 2015; 87: 871–884
4. Centers for Disease Control and Prevention. Understanding the epidemiologic triangle through infectious disease, 2012. CDC.gov. Principles of Epidemiology, Lesson 1- Section 8. [online]. 2012. Available at: https://www.cdc.gov/ophss/csels/dsepd/ss1978/lesson1/section8.html [Accessed 6 November 2017]
5. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725–1725
6. Guzmán J, Cardiel MH, Arce-Salinas A, Sánchez-Guerrero J, Alarcón-Segovia D. Measurement of disease activity in systemic lupus erythematosus. Prospective validation of 3 clinical indices. J Rheumatol 1992; 19: 1551–1558
7. Bhatla N, Cain J, Nahida C, et al. Global guidance for cervical cancer prevention and control [Internet]. 2009. Available at: http://www.rho.org/files/FIGO_cervical_cancer_guidelines_2009.pdf [Accesed 31 October 2017]
8. Biernat-Sudolska M, Szostek S, Rojek-Zakrzewska D, Klimek M, Kosz-Vnenchak M. Concomitant infections with human papillomavirus and various mycoplasma and ureaplsasma species in women with abnormal cervical cytology. Adv Med Sci 2011; 56: 299–303
9. Rositch AF, Koshiol J, Hudgens MG, Patterns of persistent genital human papillomavirus infection among women worldwide: A literature review and meta-analysis. Int J Cancer 2013; 133: 1271–1285
10. Skinner SR, Wheeler CM, Romanowski B, Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study. Int J Cancer 2016; 138: 2428–2438
11. García-Carrasco M, Mendoza-Pinto C, Ayón-Aguilar J, Serum levels of vitamin D in systemic lupus erythematosus patients (SLE) and their relationship with disease activity: Longitudinal study [article in Spanish]. Gac Med Mex 2016; 152(Suppl 2): 32–37
12. Mendoza-Pinto C, Méndez-Martínez S, Soto-Santillán P, Socioeconomic status and organ damage in Mexican systemic lupus erythematosus women. Lupus 2015; 24: 1227–1232
13. Taheri M, Baheiraei A, Foroushani AR, Nikmanesh B, Modarres M. Treatment of vitamin D deficiency is an effective method in the elimination of asymptomatic bacterial vaginosis: A placebo-controlled randomized clinical trial. Indian J Med Res 2015; 141: 799–806
14. García-Carrasco M, Mendoza-Pinto C, Munguía-Realpozo P, Lack of association between serum 25-hydroxyvitamin D levels and cervical human papillomavirus infection in systemic lupus erythematosus. Lupus 2015; 24: 606–612
15. Bernatsky S, Fournier M, Pineau CA, Clarke AE, Vinet E, Smargiassi A. Associations between ambient fine particulate levels and disease activity in patients with systemic lupus erythematosus (SLE). Environ Health Perspect 2011; 119: 45–49